Active ingredients supplier Yamamoto Chemical Industry has been blocked from shipping its products after an inspection revealed the Japanese supplier had been mixing in cheap Chinese paracetamol without clearance from regulators.
Firms which source paracetamol, also known as acetaminophen, from Yamamoto include Nihon Generic, Ayumi Pharmaceutical, Shionogi (TYO: 4507) and Taisho Pharmaceutical.
Pharma Japan reports that affected pharmaceutical companies are “considering sourcing ingredients from other suppliers,” although the Japanese health ministry has declared there were no safety or quality concerns, making a recall unnecessary.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze